Report of the Special Committee on Pharmaceutical Benefits, May 1957 PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Report of the Special Committee on Pharmaceutical Benefits, May 1957 PDF full book. Access full book title Report of the Special Committee on Pharmaceutical Benefits, May 1957 by . Download full books in PDF and EPUB format.
Author:
Publisher:
ISBN:
Category : Pharmaceutical policy
Languages : en
Pages : 25
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category : Pharmaceutical policy
Languages : en
Pages : 25
Get Book Here
Book Description
Author: New Zealand. Committee on Pharmaceutical Benefits
Publisher:
ISBN:
Category : Medicine, State
Languages : en
Pages : 26
Get Book Here
Book Description
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Get Book Here
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Author: John McEwan
Publisher:
ISBN: 9780980422900
Category : Drugs
Languages : en
Pages : 170
Get Book Here
Book Description
Author: General Assembly Library
Publisher:
ISBN:
Category : New Zealand
Languages : en
Pages : 640
Get Book Here
Book Description
Author: United States. Congress. Senate. Special Committee on Aging
Publisher:
ISBN:
Category : Legislative hearings
Languages : en
Pages : 1056
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category : New Zealand
Languages : en
Pages : 438
Get Book Here
Book Description
Author: New Zealand. Parliamentary Library
Publisher:
ISBN:
Category : New Zealand
Languages : en
Pages : 456
Get Book Here
Book Description
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Get Book Here
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Author: United States. Surgeon General's Advisory Committee on Smoking and Health
Publisher:
ISBN:
Category : Smoking
Languages : en
Pages : 406
Get Book Here
Book Description
